Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Theravance Biopharma, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Theravance Biopharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Theravance Biopharma, Inc. since 2005.
The reporting company's ticker symbol is TBPH. The reporting company's CIK number is 1583107.
The total value of stock buying since 2005 is $29,986,811,831,008.
The total value of stock sales since 2005 is $3,487,661.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-06||Shafer Bradford J (EVP, Gen. Counsel, Secretary)||Sale||14,670||30.77||451,351|
|2017-08-21||Pasqualone Frank (SVP, Chief Comm Ops Officer)||Buy||4,000||26.34||105,360|
|2017-08-11||Winningham Rick E (Chief Executive Officer)||Buy||10,000||24.50||245,000|
|2017-08-11||Whitesides George M||Buy||4,000||24.69||98,764|
|2017-08-11||Malkiel Burton G||Buy||30,000||24.59||737,670|
|2017-03-07||Haumann Brett K (SVP Clin Dev & Chief Med Ofc)||Sale||424||30.80||13,059|
|2017-03-06||Haumann Brett K (SVP Clin Dev & Chief Med Ofc)||Sale||13,576||31.52||427,915|
|2017-03-03||Shafer Bradford J (EVP, Gen. Counsel, Secretary)||Sale||26,829||31.86||854,771|
|2016-08-25||Haumann Brett K (SVP Clin Dev & Chief Med Ofc)||Sale||4,491||27.99||125,703|
|2016-08-22||Shafer Bradford J (EVP, Gen. Counsel, Secretary)||Sale||37,078||27.16||1,007,038|
|2016-08-19||Haumann Brett K (SVP Clin Dev & Chief Med Ofc)||Sale||9,509||27.97||265,966|
|2016-08-19||Shafer Bradford J (EVP, Gen. Counsel, Secretary)||Sale||4,870||28.14||137,041|
|2016-08-18||Shafer Bradford J (EVP, Gen. Counsel, Secretary)||Sale||7,174||28.55||204,817|
|2015-08-18||Lee Junning (Sr. VP, Technical Operations)||Buy||9,000||12.90||116,100|
|2015-08-18||Malkiel Burton G||Buy||10,000||12.92||129,200|
|2015-08-17||Gala Renee D (SVP, Chief Financial Officer)||Buy||5,000||12.16||60,800|
|2015-08-17||Winningham Rick E (Chief Executive Officer)||Buy||16,860||12.13||204,511|
|2015-08-14||Winningham Rick E (Chief Executive Officer)||Buy||63,140||11.79||744,420|
|2015-08-13||Gala Renee D (SVP, Chief Financial Officer)||Buy||5,000||12.19||60,950|
Insider trading activities including stock purchases, stock sales, and option exercises of TBPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Theravance Biopharma, Inc. (symbol TBPH, CIK number 1583107) see the Securities and Exchange Commission (SEC) website.